This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04684/identifier/pdb/
n11http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB04684/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB04684/identifier/pubchem-substance/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04684/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04684
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB04684 n12:DB04684
dcterms:title
BIS(HEXAMETHYLENE)TRIAMINE
adms:identifier
n6:8924 n7:46507515 n8:DB04684 n9:DRE
n3:synthesisReference
Robert A. Smiley, "Preparation of bis(hexamethylene)triamine." U.S. Patent US4906783, issued July, 1986.
n3:IUPAC-Name
n4:271B49AB-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B49B1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B49B0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B49AD-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B49AE-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B49AF-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B49A9-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B49A7-363D-11E5-9242-09173F13E4C5 n4:271B49AA-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B49A8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B49B7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B49B8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B49B2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B49B3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B49B5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B49B4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B49B6-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B49BC-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B49BE-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B49BF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B49BB-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B49BA-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B49BD-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B49AC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B49B9-363D-11E5-9242-09173F13E4C5